Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating activities
Net income	$ 42,536	$ 78,255
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	86,072	5,738
Depreciation, amortization and accretion	11,789	16,027
Deferred income tax (benefit) expense	(608)	1,142
Proceeds from sale of MSR	9,353	23,011
Gain on sale of MSR	(1,467)	(3,472)
Funding of mortgage loans held for sale	(794,785)	(641,131)
Proceeds from sales of mortgage loans held for sale	698,716	561,475
Gains on sales of mortgage loans held for sale	(9,816)	(9,734)
Debt prepayment benefit	0	(56)
(Gains) losses on sales of premises and equipment	(347)	52
Stock-based compensation expense	8,084	7,366
Decrease (increase) in other assets	4,335	(6,802)
Decrease in other liabilities	(25,001)	(15,891)
Net cash provided by operating activities	28,861	15,980
Investing activities
Purchases of securities available for sale	(946,095)	(52,679)
Proceeds from sales of securities available for sale	686,485	177,185
Proceeds from call/maturities of securities available for sale	113,025	42,713
Proceeds from call/maturities of securities held to maturity	52,352	50,372
Net increase in loans	(480,005)	(258,608)
Purchases of premises and equipment	(14,996)	(6,774)
Proceeds from sales of premises and equipment	1,346	289
Proceeds from surrender of bank-owned life insurance	56,255	0
Net change in FHLB stock	(5,683)	2,665
Proceeds from sales of other assets	11,778	1,167
Net cash received in acquisition of businesses	261,483	0
Other, net	1,882	191
Net cash used in investing activities	(262,173)	(43,479)
Financing activities
Net increase (decrease) in noninterest-bearing deposits	164,306	(44,222)
Net increase in interest-bearing deposits	391,930	222,650
Net decrease in short-term borrowings	(919)	(74,836)
Repayment of long-term debt	0	(245)
Cash paid for dividends	(35,425)	(25,293)
Net cash provided by financing activities	519,892	78,054
Net increase in cash and cash equivalents	286,580	50,555
Cash and cash equivalents at beginning of period	1,092,032	801,351
Cash and cash equivalents at end of period	1,378,612	851,906
Supplemental disclosures
Cash paid for interest	199,936	187,194
Cash paid for income taxes	21,088	17,958
Noncash transactions:
Transfers of loans to other real estate owned	4,281	1,135
Common stock issued in acquisition of businesses	1,059,911	0
Recognition of operating right-of-use assets	12,251	1,562
Recognition of operating lease liabilities	$ 12,251	$ 1,562

RENASANT CORP 10-Q